Annual Shareholders Equity
-$6.44 M
-$2.74 M-73.87%
December 31, 2023
Summary
- As of February 7, 2025, CHRO annual stockholders equity is -$6.44 million, with the most recent change of -$2.74 million (-73.87%) on December 31, 2023.
- During the last 3 years, CHRO annual shareholders equity has fallen by -$2.87 million (-80.12%).
- CHRO annual shareholders equity is now -80.12% below its all-time high of -$3.58 million, reached on December 1, 2020.
Performance
CHRO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$1.43 M
-$1.24 M-682.10%
September 30, 2024
Summary
- As of February 7, 2025, CHRO quarterly stockholders equity is -$1.43 million, with the most recent change of -$1.24 million (-682.10%) on September 30, 2024.
- Over the past year, CHRO quarterly shareholders equity has increased by +$5.02 million (+77.85%).
- CHRO quarterly shareholders equity is now -103.46% below its all-time high of $41.28 million, reached on September 1, 2022.
Performance
CHRO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CHRO Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -73.9% | +77.8% |
| 3 y3 years | -80.1% | -103.5% |
| 5 y5 years | -80.1% | -103.5% |
CHRO Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -75.1% | at low | -103.5% | +77.8% |
| 5 y | 5-year | -80.1% | at low | -103.5% | +77.8% |
| alltime | all time | -80.1% | at low | -103.5% | +77.8% |
Chromocell Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$1.43 M(+682.1%) |
| Jun 2024 | - | -$182.52 K(-116.2%) |
| Mar 2024 | - | $1.13 M(-117.5%) |
| Dec 2023 | -$6.44 M | -$6.44 M(+9.1%) |
| Sep 2023 | - | -$5.90 M(+20.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | -$4.90 M(+11.4%) |
| Mar 2023 | - | -$4.40 M(+18.7%) |
| Dec 2022 | -$3.71 M(+0.7%) | -$3.71 M(-109.0%) |
| Sep 2022 | - | $41.28 M(-1221.7%) |
| Dec 2021 | -$3.68 M(+2.9%) | -$3.68 M |
| Dec 2020 | -$3.58 M | - |
FAQ
- What is Chromocell Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Chromocell Therapeutics?
- What is Chromocell Therapeutics annual shareholders equity year-on-year change?
- What is Chromocell Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Chromocell Therapeutics?
- What is Chromocell Therapeutics quarterly shareholders equity year-on-year change?
What is Chromocell Therapeutics annual stockholders equity?
The current annual shareholders equity of CHRO is -$6.44 M
What is the all time high annual shareholders equity for Chromocell Therapeutics?
Chromocell Therapeutics all-time high annual stockholders equity is -$3.58 M
What is Chromocell Therapeutics annual shareholders equity year-on-year change?
Over the past year, CHRO annual stockholders equity has changed by -$2.74 M (-73.87%)
What is Chromocell Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of CHRO is -$1.43 M
What is the all time high quarterly shareholders equity for Chromocell Therapeutics?
Chromocell Therapeutics all-time high quarterly stockholders equity is $41.28 M
What is Chromocell Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, CHRO quarterly stockholders equity has changed by +$5.02 M (+77.85%)